Defining Surgical Indications for Type I Gastric Carcinoid Tumor
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Background Most gastric carcinoid tumors (GC) (type I) occur in association with achlorhydria, hypergastrinemia, atrophic gastritis and exhibit low-grade histopathology. The management of this indolent disease is controversial. The aim of this study was to evaluate endoscopic surveillance (ES) compare with surgical resection (SR) for type I GC.Methods Between 1985 and 2007, 65 patients with type IGC were identified. Data analysis included: demographics, biochemical and endoscopic assessment, type of operation performed, and pathologic evaluation. The primary endpoints were disease-specific survival (DSS) in both groups and recurrence-free survival (RFS) in SR patients.Results Median follow-up was 30 months (range 1-176 months); most patients were female (83%) with median age of 58 years (range 29-91 years). Type I GC was diagnosed by evidence of hypergastrinemia and/or positive autoimmune antibodies with histopathologic confirmation. Patients underwent ES with polypectomy (n=46) or gastric resection (n=19). SR was performed with larger tumor size, increased depth of invasion, and solitary tumors. Although the 5-year RFS in SR patients was 75%, the DSS in both groups was 100%. However, concomitant adenocarcinoma was identified in 4/19 resected cases; 2/4 were detected on preoperative biopsies. All cases with coexisting gastric adenocarcinoma had larger carcinoid tumors and more advanced carcinoid disease.Conclusions The DSS is excellent for type I GC patients treated with either ES or SR. SR should be considered with more advanced carcinoid disease given its association with an increased risk of adenocarcinoma. ES is appropriate to assess both the status of carcinoid disease and dysplasia or adenocarcinoma that can develop in association with type I GC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These usually appear as small to tiny nodules <10 mm and are most often found at the gastric corpus or fundus; they are typically well-differentiated with an indolent course.85–88”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [85]
In the citing paper
“Small NETs are typically asymptomatic and often diagnosed incidentally.”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [85]
In the citing paper
“Small NETs are typically asymptomatic and often diagnosed incidentally.”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [85]
In the citing paper
“These usually appear as small to tiny nodules <10 mm and are most often found at the gastric corpus or fundus; they are typically well-differentiated with an indolent course.85–88”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [85]
In the citing paper
“These usually appear as small to tiny nodules <10 mm and are most often found at the gastric corpus or fundus; they are typically well-differentiated with an indolent course.85–88”
From AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review (2021) · cites this paper as [85]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Apoptosis. Its significance in cancer and cancer Therapy
Kerr, J. F. R., Winterford, C. M., & HARMON, B. V. (1994) · Cancer · doi:10.1002/1097-0142(19940415)73:8<2157::aid-cncr2820730821>3.0.co;2-1 · Cited by 2,135
Rindi, G., Luinetti, O., Cornaggia, M., Capella, C., & Solcia, E. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90266-f · Cited by 644
Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior
Rindi, G., Bordi, C., Rappel, S., La Rosa, S., Stolte, M., & Solcia, E. (1996) · World Journal of Surgery · doi:10.1007/s002689900026 · Cited by 433
Rindi, G., Azzoni, C., Rosa, S. L., Klersy, C., Paolotti, D., Rappel, S., Stolte, M., Capella, C., Bordi, C., & Solcia, E. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70174-5 · Cited by 354
Pernicious anemia and subsequent cancer. A population-based cohort study
Hsing, A. W., Hansson, L.-E., McLaughlin, J. K., Nyren, O., Blot, W. J., Ekbom, A., & Fraumeni, J. F. (1993) · Cancer · doi:10.1002/1097-0142(19930201)71:3<745::aid-cncr2820710316>3.0.co;2-1 · Cited by 310
Borch, K., Ahrén, B., Ahlman, H., Falkmer, S., Granérus, G., & Grimelius, L. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000167862.52309.7d · Cited by 287
A 50-Year Analysis of 562 Gastric Carcinoids: Small Tumor or Larger Problem?
Modlin, I. M., Lye, K. D., & Kidd, M. (2004) · American Journal of Gastroenterology · doi:10.1046/j.1572-0241.2003.04027.x · Cited by 217
Carcinoid tumors of the stomach
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Surgical Oncology · doi:10.1016/s0960-7404(03)00034-3 · Cited by 205
Hirschowitz, B., Griffith, J., Pellegrin, D., & Cummings, O. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)70044-c · Cited by 185
Research works printed but not linked: 1
- Hamilton SR, Aaltonen LA. World Health Organization classification of tumors, pathology and genetics of tumors of the digestive system. Lyon: IARC; 2000.
Cited by
AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review
Shah, S. C., Piazuelo, M. B., Kuipers, E. J., & Li, D. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.06.078 · Cited by 560
S2k-Leitlinie Neuroendokrine Tumore: AWMF-Reg. 021-27
Authors, Collaborators:, Deutsche Gesellschaft für Gastroenterologie, V. U. S. (., (Patientenvertretung), N. N. T. (. E. V., (Patientenvertretung), B. S. N. T. E. V. (.-S., Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V. (DGHO), U. A. I. O. (. D. D. K. E. V., (DGAV), D. G. F. A. U. V. E. V., (DGCH), D. G. F. C., (DGEBV), D. G. F. E. U. B. V., (DGNM), D. G. F. N. E. V., et al. (2018) · Zeitschrift für Gastroenterologie · doi:10.1055/a-0604-2924 · Cited by 180
Review article: the investigation and management of gastric neuroendocrine tumours
Basuroy, R., Srirajaskanthan, R., Prachalias, A., Quaglia, A., & Ramage, J. K. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12698 · Cited by 180
Management of gastric and duodenal neuroendocrine tumors
Sato, Y., Hashimoto, S., Mizuno, K.-I., Takeuchi, M., & Terai, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i30.6817 · Cited by 161
Mocellin, S., & Nitti, D. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt377 · Cited by 136
Metadata
- Authors
- Gladdy, R. A., Strong, V. E., Coit, D., Allen, P. J., Gerdes, H., Shia, J., Klimstra, D. S., Brennan, M. F., & Tang, L. H.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Tang, Laura H.
- ORCID
- Venue
- Annals of Surgical Oncology
- Published
- 2009-09-01
- Volume
- 16
- Issue
- 11
- Pages
- 3154-3160
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- OpenAlex
- W2132350514
- Cited by
- 112
- References
- 36
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 4 · 2023: 6 · 2022: 4 · 2021: 11 · 2020: 10 · 2019: 9 · 2018: 5 · 2017: 7 · 2016: 7 · 2015: 7 · 2014: 6 · 2013: 6 · 2012: 5
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Annals of Surgical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Keywords
- surgical indications, endoscopic surveillance, surgical resection, gastric resection, polypectomy, disease-specific survival, recurrence-free survival, gastric adenocarcinoma, hypergastrinemia, achlorhydria, atrophic gastritis, dysplasia
- MeSH terms
- Adenocarcinoma, Adult, Aged, Aged, 80 and over, Carcinoid Tumor, Female, Follow-Up Studies, Gastroscopy, Humans, Male, Middle Aged, Neoplasm Staging, Prognosis, Prospective Studies, Stomach Neoplasms, Survival Rate, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Defining Surgical Indications for Type I Gastric Carcinoid Tumor. https://app.cochat.ai/papers/10.1245/s10434-009-0687-y
- The paper
- Gladdy, R. A., Strong, V. E., Coit, D., Allen, P. J., Gerdes, H., Shia, J., Klimstra, D. S., Brennan, M. F., & Tang, L. H. (2009). Defining Surgical Indications for Type I Gastric Carcinoid Tumor. Annals of Surgical Oncology. https://doi.org/10.1245/s10434-009-0687-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.